Citadel Advisors
MTEM

Citadel Advisors’s Molecular Templates, Inc. MTEM Stock Holding History

Citadel Advisors’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,780
Closed -$92K – 14557
2022
Q1 		$92K Sell
1,780
-60
-3% -$2.65K ﹤0.01% 12367
2021
Q4 		$108K Buy
1,840
+773
+72% +$57.9K ﹤0.01% 12644
2021
Q3 		$107K Sell
1,067
-260
-20% -$26.8K ﹤0.01% 12796
2021
Q2 		$156K Sell
1,327
-693
-34% -$90.7K ﹤0.01% 12464
2021
Q1 		$382K Buy
2,020
+687
+52% +$120K ﹤0.01% 10297
2020
Q4 		$188K Buy
+1,333
New +$197K ﹤0.01% 9789
2016
Q1 		– Sell
-66
Closed -$5K – 8265
2015
Q4 		$5K Buy
66
+17
+35% +$8.38K ﹤0.01% 8460
2015
Q3 		$33K Buy
49
+34
+227% +$24.2K ﹤0.01% 7859
2015
Q2 		$10K Buy
15
+3
+25% +$1.98K ﹤0.01% 8409
2015
Q1 		$8K Sell
12
-59
-83% -$38.8K ﹤0.01% 8250
2014
Q4 		$37K Sell
71
-13
-15% -$6.5K ﹤0.01% 7414
2014
Q3 		$50K Buy
84
+46
+121% +$31.8K ﹤0.01% 6908
2014
Q2 		$25K Sell
38
-8
-17% -$5.3K ﹤0.01% 7193
2014
Q1 		$36K Sell
46
-75
-62% -$60.9K ﹤0.01% 6992
2013
Q4 		$93K Sell
121
-3
-2% -$2.26K ﹤0.01% 5668
2013
Q3 		$95K Buy
124
+60
+94% +$49.3K ﹤0.01% 5388
2013
Q2 		$55K Buy
+64
New +$54.1K ﹤0.01% 5616

Other funds holding MTEM

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Citadel Advisors's MTEM Position: Q3 2022 in Review

Citadel Advisors sold out of Molecular Templates, Inc. (MTEM) in Q3 2022, closing a stake of 8,362 shares — an estimated $114K sold.

Citadel Advisors first reported a position in MTEM in Q2 2013 and held it in 23 quarters. The position peaked at $701K in Q3 2015. 58 funds tracked by Wall St. Rank hold MTEM as of Q3 2022.

  • Citadel Advisors reported no remaining Molecular Templates, Inc. position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 8,362 Molecular Templates, Inc. shares in Q3 2022, an estimated $114K.
  • Citadel Advisors first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 23 quarters.
  • Citadel Advisors's Molecular Templates, Inc. position peaked at $701K in Q3 2015.
  • 58 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.